<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:media="http://search.yahoo.com/mrss/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>MicroRNA &#8211; USA NEWS LIVE</title>
	<atom:link href="https://bloggingthree.soflytech.com/tag/microrna/feed/" rel="self" type="application/rss+xml" />
	<link>https://bloggingthree.soflytech.com</link>
	<description>All About USA NEWS</description>
	<lastBuildDate>Thu, 17 Oct 2024 21:23:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://bloggingthree.soflytech.com/wp-content/uploads/2024/04/cropped-THE-USA1-e1713184454543-1-32x32.png</url>
	<title>MicroRNA &#8211; USA NEWS LIVE</title>
	<link>https://bloggingthree.soflytech.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>MicroRNA – a brand new Nobel Prize winner describes the scientific technique of discovering these tiny molecules that turn genes on and off</title>
		<link>https://bloggingthree.soflytech.com/2024/10/microrna-a-brand-new-nobel-prize-winner-describes-the-scientific-technique-of-discovering-these-tiny-molecules-that-turn-genes-on-and-off/</link>
		
		<dc:creator><![CDATA[chandankumarsoft]]></dc:creator>
		<pubDate>Thu, 17 Oct 2024 21:23:29 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[describes]]></category>
		<category><![CDATA[discovering]]></category>
		<category><![CDATA[genes]]></category>
		<category><![CDATA[MicroRNA]]></category>
		<category><![CDATA[molecules]]></category>
		<category><![CDATA[Nobel]]></category>
		<category><![CDATA[Prize]]></category>
		<category><![CDATA[process]]></category>
		<category><![CDATA[scientific]]></category>
		<category><![CDATA[tiny]]></category>
		<category><![CDATA[turn]]></category>
		<category><![CDATA[winner]]></category>
		<guid isPermaLink="false">https://bloggingthree.soflytech.com/?p=17502</guid>

					<description><![CDATA[How did you begin fascinated with this fundamental query at the center of the invention of microRNA: How cells receive the instructions to do what they do? The A paper describing this discovery was published in 1993. In the late Nineteen Eighties we worked and studied in the sphere of developmental biology as a model [&#8230;]]]></description>
										<content:encoded><![CDATA[<p></p>
<div itemprop="articleBody">
</p>
<p><strong>How did you begin fascinated with this fundamental query at the center of the invention of microRNA: How cells receive the instructions to do what they do?</strong></p>
<p>The <a href="https://doi.org/10.1016/0092-8674(93)90529-y">A paper describing this discovery was published in 1993</a>. In the late Nineteen Eighties we worked and studied in the sphere of developmental biology <a href="https://www.ncbi.nlm.nih.gov/books/NBK20086/"> as a model organism</a> for animal development. We used genetic approaches that tracked mutations that caused developmental disorders to know which gene was mutated and what gene product it was.</p>
<p>It was well-known that proteins could mediate changes in gene expression as cells differentiate and divide.</p>
<p>We didn&#8217;t search for the involvement of unexpected molecular mechanisms. The proven fact that the microRNA was the product of this gene, which on this context regulated this other gene, was an entire surprise.</p>
<p>There was no reason to consider that there must be such regulators of gene expression. This is one in every of those examples where you&#39;re expected to learn more concerning the complexities and nuances of the mechanisms we already know.</p>
<p>But sometimes there are surprises, and in truth surprises are perhaps surprisingly common.</p>
<figure class="align-center zoomable">
<div class="placeholder-container" style="--aspect-ratio-percent:85.6763925729443%;--background-color:#2e4157"><img decoding="async" alt="orange and pink worm" class="lazyload" src="https://images.theconversation.com/files/626044/original/file-20241015-19-8jh1p9.jpg?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=754&#038;fit=clip" srcset="https://images.theconversation.com/files/626044/original/file-20241015-19-8jh1p9.jpg?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=600&#038;h=514&#038;fit=crop&#038;dpr=1 600w, https://images.theconversation.com/files/626044/original/file-20241015-19-8jh1p9.jpg?ixlib=rb-4.1.0&#038;q=30&#038;auto=format&#038;w=600&#038;h=514&#038;fit=crop&#038;dpr=2 1200w, https://images.theconversation.com/files/626044/original/file-20241015-19-8jh1p9.jpg?ixlib=rb-4.1.0&#038;q=15&#038;auto=format&#038;w=600&#038;h=514&#038;fit=crop&#038;dpr=3 1800w, https://images.theconversation.com/files/626044/original/file-20241015-19-8jh1p9.jpg?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=754&#038;h=646&#038;fit=crop&#038;dpr=1 754w, https://images.theconversation.com/files/626044/original/file-20241015-19-8jh1p9.jpg?ixlib=rb-4.1.0&#038;q=30&#038;auto=format&#038;w=754&#038;h=646&#038;fit=crop&#038;dpr=2 1508w, https://images.theconversation.com/files/626044/original/file-20241015-19-8jh1p9.jpg?ixlib=rb-4.1.0&#038;q=15&#038;auto=format&#038;w=754&#038;h=646&#038;fit=crop&#038;dpr=3 2262w" sizes="(min-width: 1466px) 754px, (max-width: 599px) 100vw, (min-width: 600px) 600px, 237px"></div><figcaption>
              <span class="caption">Colorized scanning electron microscope image of a nematode worm – one of the vital commonly studied animals in biological research.</span><br />
              <span class="attribution"><a class="source" href="https://www.gettyimages.com/detail/photo/elegans-sem-royalty-free-image/1128676754">Steve Gschmeissner/Science Photo Library via Getty Images</a></span><br />
            </figcaption></figure>
<p><strong>Is there something about these worms, nematodes, that means that you can work with their genetic material more easily? Why are they so necessary for any such science?</strong></p>
<p>    was developed as an experimental organism that folks could easily use to first discover mutants after which study development.</p>
<p>It only has a few thousand cells, and all of those cells could be easily seen within the living animal through a microscope. Yet it has all different parts which can be necessary to all animals: intestines, skin, muscles, a brain, sensory systems and sophisticated behavior. So it&#39;s a reasonably amazing system to actually study developmental processes and mechanisms at the extent of individual cells and what those cells do as they divide and differentiate during development.</p>
<hr>
<p><iframe src="https://embed.acast.com/60087127b9687759d637bade/670f708ae06ec721112ae6d4" frameborder="0" width="100%" height="190px"></iframe></p>
<hr>
<p><strong>They checked out this gene. What was your surprising discovery that led to this Nobel Prize?</strong></p>
<p>In our laboratory <a href="https://scholar.google.com/citations?hl=en&#038;user=m6Wsx_AAAAAJ">Rosalind Lee</a> And <a href="https://www.umassmed.edu/ambroslab/LabMembersOnly/alumni/">Rhonda Feinbaum</a> have worked on this project for several years. This is a really labor-intensive process attempting to track down a gene.</p>
<p>And all we would have liked was a mutation that may progressively bring us closer to the DNA sequence that contained the gene. The surprises got here once we found that the pieces of DNA that were enough to transfer the function of this gene and rescue a mutant were really small, only 800 base pairs.</p>
<p>So that suggested that the gene is small, so the product of this gene might be quite small. And then Rosalind worked to further reduce the sequence and mutate potential protein-coding sequences on this small piece of DNA. Through an elimination process, she finally showed that there was no protein that might be expressed from this gene.</p>
<p>And at the identical time, we identified this very, very small transcript of just 22 nucleotides. So I&#8217;d say there was probably per week or two time frame where these insights emerged and we knew we had something latest.</p>
<p><strong>You mentioned Rosalind, she is your wife.</strong></p>
<p>Yes, we&#39;ve been together since 1976. And we began working together within the mid-80s. And that&#39;s how we still work together today.</p>
<p><strong>And she was the primary writer of this work.</strong></p>
<p>That&#39;s right. It is difficult to precise how wonderful it&#8217;s to receive such acknowledgment of our work together. That is just priceless.</p>
<figure class="align-center zoomable">
<div class="placeholder-container" style="--aspect-ratio-percent:78.24933687002653%;--background-color:#2e3056"><img decoding="async" alt="Smiling man and woman wearing full coupe glasses" class="lazyload" src="https://images.theconversation.com/files/626034/original/file-20241015-15-garrx0.JPG?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=754&#038;fit=clip" srcset="https://images.theconversation.com/files/626034/original/file-20241015-15-garrx0.JPG?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=600&#038;h=470&#038;fit=crop&#038;dpr=1 600w, https://images.theconversation.com/files/626034/original/file-20241015-15-garrx0.JPG?ixlib=rb-4.1.0&#038;q=30&#038;auto=format&#038;w=600&#038;h=470&#038;fit=crop&#038;dpr=2 1200w, https://images.theconversation.com/files/626034/original/file-20241015-15-garrx0.JPG?ixlib=rb-4.1.0&#038;q=15&#038;auto=format&#038;w=600&#038;h=470&#038;fit=crop&#038;dpr=3 1800w, https://images.theconversation.com/files/626034/original/file-20241015-15-garrx0.JPG?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=754&#038;h=590&#038;fit=crop&#038;dpr=1 754w, https://images.theconversation.com/files/626034/original/file-20241015-15-garrx0.JPG?ixlib=rb-4.1.0&#038;q=30&#038;auto=format&#038;w=754&#038;h=590&#038;fit=crop&#038;dpr=2 1508w, https://images.theconversation.com/files/626034/original/file-20241015-15-garrx0.JPG?ixlib=rb-4.1.0&#038;q=15&#038;auto=format&#038;w=754&#038;h=590&#038;fit=crop&#038;dpr=3 2262w" sizes="(min-width: 1466px) 754px, (max-width: 599px) 100vw, (min-width: 600px) 600px, 237px"></div><figcaption>
              <span class="caption">Victor Ambros and Rosalind Lee toast the Nobel news on the day of the announcement.</span><br />
              <span class="attribution"><span class="source">UMass Chan Medical School</span></span><br />
            </figcaption></figure>
<p><strong>As if it were a Nobel Prize for them too?</strong></p>
<p>Yes, every Nobel Prize is subject to this obvious limitation on the number of individuals to whom it&#8217;s awarded. But behind it, after all, are the individuals who worked within the lab &#8211; the teams actually behind the discoveries are sometimes surprisingly large. In this case, two people in my lab and a number of other people in Gary Ruvkun&#39;s lab.</p>
<p>In a way, they are surely the heroes behind all of it. Our job &#8211; mine and Gary&#39;s &#8211; is to act as representatives of this complete scientific enterprise that&#8217;s so, so depending on teams, collaboration, brainstorming between multiple people, communication of ideas and necessary data, you understand, all of that is a component of it Process that underlies successful science.</p>
<p><strong>Did you anticipate in the primary week of discoveries that this might be such an enormous step forward in our understanding of genes?</strong></p>
<p>Until more examples of something latest are found, it is rather difficult to say how peculiar this particular phenomenon is likely to be.</p>
<p>We are at all times aware that evolution is amazingly progressive. And so it might be that this special small RNA base pairing with this mRNA of the gene and turning off the production of the protein from messenger RNA might be a special evolutionary innovation.</p>
<p>The second microRNA was identified in <a href="https://www.ruvkun.hms.harvard.edu">Gary Ruvkun&#39;s lab</a> in 1999, so it took a superb six years until the second specimen was also found. The turning point was really the invention when Ruvkun showed this <a href="https://doi.org/10.1038/35040556">the opposite microRNA</a>was actually preserved in perfect order amongst all of them <a href="https://www.britannica.com/animal/Bilateria">bilateral animals</a>. So that meant microRNA had been around for about 500 million years?</p>
<p>And so it was immediately clear to the sphere that there needed to be other microRNAs &#8211; it wasn&#39;t only one thing. There should be others, and that quickly became apparent.</p>
<figure class="align-center zoomable">
<div class="placeholder-container" style="--aspect-ratio-percent:42.30769230769231%;--background-color:#9f5c52"><img decoding="async" alt="Representation of microRNA pairing with the RNA of another gene" class="lazyload" src="https://images.theconversation.com/files/626036/original/file-20241015-17-4iy098.jpg?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=754&#038;fit=clip" srcset="https://images.theconversation.com/files/626036/original/file-20241015-17-4iy098.jpg?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=600&#038;h=254&#038;fit=crop&#038;dpr=1 600w, https://images.theconversation.com/files/626036/original/file-20241015-17-4iy098.jpg?ixlib=rb-4.1.0&#038;q=30&#038;auto=format&#038;w=600&#038;h=254&#038;fit=crop&#038;dpr=2 1200w, https://images.theconversation.com/files/626036/original/file-20241015-17-4iy098.jpg?ixlib=rb-4.1.0&#038;q=15&#038;auto=format&#038;w=600&#038;h=254&#038;fit=crop&#038;dpr=3 1800w, https://images.theconversation.com/files/626036/original/file-20241015-17-4iy098.jpg?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=754&#038;h=319&#038;fit=crop&#038;dpr=1 754w, https://images.theconversation.com/files/626036/original/file-20241015-17-4iy098.jpg?ixlib=rb-4.1.0&#038;q=30&#038;auto=format&#038;w=754&#038;h=319&#038;fit=crop&#038;dpr=2 1508w, https://images.theconversation.com/files/626036/original/file-20241015-17-4iy098.jpg?ixlib=rb-4.1.0&#038;q=15&#038;auto=format&#038;w=754&#038;h=319&#038;fit=crop&#038;dpr=3 2262w" sizes="(min-width: 1466px) 754px, (max-width: 599px) 100vw, (min-width: 600px) 600px, 237px"></div><figcaption>
              <span class="caption">Ambros discovered that the gene encoded a microRNA that didn&#8217;t encode a protein. Ruvkun cloned the gene and the 2 scientists realized that the microRNA sequence matched a complementary sequence within the mRNA.</span><br />
              <span class="attribution"><a class="source" href="https://www.nobelprize.org/prizes/medicine/2024/press-release/">© The Nobel Committee for Physiology or Medicine. Fig. Mattias Karlén</a></span><br />
            </figcaption></figure>
<p><strong>You and Gary Ruvkun were postdoctoral fellows at MIT at the identical time, but by the point you made your respective discoveries you had each established your personal labs. Would you describe them as rival labs in the identical city?</strong></p>
<p>No, I&#8217;d definitely not call it a competitive lab. We essentially worked on this problem of development timing as postdocs <a href="https://www.nobelprize.org/prizes/medicine/2002/horvitz/facts/">Bob Horvitz&#39;s laboratory</a>.</p>
<p>We principally just divided the work informally. The agreement was, OK, the Ambros lab will give attention to genes and the Ruvkun lab will give attention to, and we assumed that there can be a degree where we&#8217;d get together and share details about what now we have learned and see if we could come to a synthesis.</p>
<p>That was the informal plan. It wasn&#39;t really a collaboration. It definitely wasn&#39;t a rivalry. The expectation was that we&#8217;d divide the work after which communicate when the time got here. There was an expectation on this research community that data must be shared freely.</p>
<p><strong>Her lab remains to be working on microRNA. What are you investigating? What questions do you continue to have?</strong></p>
<p>One that I find very interesting is a project where we worked with a clinician, a geneticist, who studies mental disability. She had found that her patients, children with mental disabilities, in certain families carried a mutation that neither of their parents had &#8211; a spontaneous mutation &#8211; within the protein related to microRNAs in humans, called the Argonaute protein.</p>
<p>Each of our genomes incorporates 4 Argonaut genes, that are the partners of microRNAs. In fact, that is the effector protein that&#8217;s guided by the microRNA to its goal messenger RNAs. This Argonaut carries out the regulatory processes that happen once it finds its goal.</p>
<p>These so-called Argonaut syndromes were discovered, wherein mutations occur in Argonauts, i.e. point mutations wherein just one amino acid changes to a different. They have this very profound and comprehensive effect on the event of the person.</p>
<p>And so our lab and other labs, working with these geneticists, extracted those mutations that were essentially gifted to us by the patient. And then <a href="https://www.umassmed.edu/news/news-archives/2024/03/umass-chan-study-reveals-new-details-about-argonaute-syndromes-a-recently-identified-class-of-neurodevelopmental-disorders">We have incorporated these mutations into our system</a>in our case in &#39;Argonaut.</p>
<p>I&#8217;m passionate about the very organized, lively partnership between the <a href="https://argonautes.ngo/en">Argonaut Alliance</a> from families with Argonaute syndromes and the essential scientists who study Argonaute.</p>
<p><strong>How can this collaboration potentially help these patients?</strong></p>
<p>We discovered that the mutated protein is a few type of rogue Argonaut. It principally messes up the conventional process that these 4 Argonauts normally have of their bodies. And so this rogue Argonaut could principally be faraway from the system by attempting to use a number of the technologies that folks are developing for <a href="https://www.britannica.com/science/gene-disruption">Gene knockout</a> or <a href="https://www.britannica.com/science/RNA-interference">RNA interference of genes</a>.</p>
<p>This is promising and I hope it can repay for patients within the years to come back.</p>
</p></div>
<p><em>image credit : theconversation.com</em></p>
]]></content:encoded>
					
		
		
		<media:content url="https://images.theconversation.com/files/626043/original/file-20241015-15-iey0ef.jpg?ixlib=rb-4.1.0&#038;rect=138%2C534%2C3904%2C1949&#038;q=45&#038;auto=format&#038;w=1356&#038;h=668&#038;fit=crop" medium="image"></media:content>
	</item>
		<item>
		<title>Berkeley native Gary Ruvkun and Victor Ambros win Nobel Prize in medicine for discovery of microRNA &#8211; The Mercury News</title>
		<link>https://bloggingthree.soflytech.com/2024/10/berkeley-native-gary-ruvkun-and-victor-ambros-win-nobel-prize-in-medicine-for-discovery-of-microrna-the-mercury-news/</link>
		
		<dc:creator><![CDATA[chandankumarsoft]]></dc:creator>
		<pubDate>Mon, 07 Oct 2024 17:27:58 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Ambros]]></category>
		<category><![CDATA[Berkeley]]></category>
		<category><![CDATA[discovery]]></category>
		<category><![CDATA[Gary]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[Mercury]]></category>
		<category><![CDATA[MicroRNA]]></category>
		<category><![CDATA[Native]]></category>
		<category><![CDATA[Nobel]]></category>
		<category><![CDATA[Prize]]></category>
		<category><![CDATA[Ruvkun]]></category>
		<category><![CDATA[Victor]]></category>
		<category><![CDATA[win]]></category>
		<guid isPermaLink="false">https://bloggingthree.soflytech.com/?p=16820</guid>

					<description><![CDATA[STOCKHOLM – Two scientists have won Nobel Prize in Physiology or Medicine on Monday for his or her discovery of microRNA, tiny pieces of genetic material that function on-and-off switches in cells and help control what the cells do and after they do it. If scientists higher understand how they work and how one can [&#8230;]]]></description>
										<content:encoded><![CDATA[<p><img decoding="async" src="https://www.mercurynews.com/wp-content/uploads/2024/10/cnn-L19jb21wb25lbnRzL2ltYWdlL2luc3RhbmNlcy9jbTF5djM0NzgwMDAxM2I2bTN6dG05eWRj-L19jb21wb25lbnRzL2FydGljbGUvaW5zdGFuY2VzL2NtMXlyZ2o1MDAwMG50YnBjY2YxNDZma2g.jpg?w=1400px&amp;strip=all" /></p>
<div>
<p>STOCKHOLM – Two scientists have won <a href="https://www.nobelprize.org/prizes/medicine/2024/press-release/">Nobel Prize in Physiology or Medicine</a> on Monday for his or her discovery of microRNA, tiny pieces of genetic material that function on-and-off switches in cells and help control what the cells do and after they do it.</p>
<p>If scientists higher understand how they work and how one can manipulate them, it could in the future result in effective treatments for diseases like cancer.</p>
<p>The work is by Americans Victor Ambros and Berkeley natives <a href="https://ccib.mgh.harvard.edu/ruvkun">Gary Ruvkun</a> “proves to be of fundamental importance for the development and function of organisms,” said a panel that awarded the prize in Stockholm.</p>
<p>Ambros and Ruvkun were initially considering genes that control the timing of varied genetic developments, ensuring that cell types develop at the correct time.</p>
<p>Their discovery ultimately revealed “a new dimension of gene regulation that is essential for all complex life forms,” the panel said.</p>
<h4>What is the Nobel Prize for?</h4>
<p>RNA is best known for passing instructions for making proteins from DNA within the cell nucleus to tiny cell factories that truly construct the proteins. MicroRNA doesn&#39;t produce proteins, but it surely helps control what cells do, including turning on and off critical genes that make proteins.</p>
<p>Last 12 months&#39;s Nobel Prize in Medicine went to scientists who discovered how one can manipulate one in every of all these RNA, called messenger RNA or mRNA, which is now used to make vaccines against COVID-19.</p>
<p>Ambros and Ruvkun&#39;s revolutionary discovery was first made on worms; They wanted to search out out why some sorts of cells didn&#8217;t evolve in two mutant worm strains commonly utilized in science as a research model.</p>
<p>“Their groundbreaking discovery revealed an entirely new principle of gene regulation that proved essential for multicellular organisms, including humans,” says the citation, explaining the importance of their work.</p>
<p>This mechanism has been at work for a whole bunch of hundreds of thousands of years and has enabled the event of complex organisms, it said.</p>
<p>Ambros, currently a professor of natural sciences on the University of Massachusetts Medical School, conducted the research at Harvard University. Ruvkun&#39;s research was conducted at Massachusetts General Hospital and Harvard Medical School, where he&#8217;s a professor of genetics.</p>
<h4>Why is microRNA vital?</h4>
<p>Fletcher said there are two principal areas where microRNA might be helpful: in developing drugs to treat diseases and as possible indicators of disease by tracking microRNA levels within the body.</p>
<p>“If we take the example of cancer, we have a particular gene that is working overtime, it could be mutated and working at full speed,” Fletcher said. She said scientists may in the future find a way to make use of microRNA to stop such effects.</p>
<p>Eric Miska, a geneticist on the University of Cambridge, said Ambros and Ruvkun&#39;s discovery was an entire surprise and upended what scientists had long understood about how cells work.</p>
<p>Their discovery of microRNA shocked many scientists, Miska said, explaining that such small pieces of genetic material had never been seen before. It later emerged that the tiny RNA fragments &#8211; the human genome has no less than 800 &#8211; play a vital role in the event of our bodies.</p>
<p>Miska said that work is currently underway on the role of microRNA in infectious diseases comparable to hepatitis and that it may be helpful in treating neurological diseases.</p>
<p>Fletcher said essentially the most advanced studies up to now are examining how microRNA approaches could help treat skin cancer, but no drugs have been approved yet. She predicted this might occur in the approaching years, adding that almost all treatments currently goal cellular proteins.</p>
<p>“If we can intervene at the microRNA level, it opens up a whole new opportunity for us to develop drugs,” she said.</p>
<h4>How did Gary Ruvkun and Victor Ambros react?</h4>
<p>The call from the Nobel Prize panel is usually a surprise, but there are specific signs that recipients and their families notice.</p>
<p>“Well, when a phone rings at 4:30 in the morning. &#8230; That never happens here,” Ruvkun said.</p>
<p>“Natasha actually responded,” Ruvkun added, referring to his wife. &#8220;And she says, &#39;He has a Swedish accent.&#39;&#8221;</p>
<p>It took just a little longer to wake Ambros.</p>
<p>“Someone called my son, who called my wife because my phone was downstairs,” he said.</p>
<p>Ruvkun immediately knew the impact the award would have on his life.</p>
<p>“Well, I kept repeating it in my head, this changes everything because the Nobel Prize is just mythical when it comes to how it changes the lives of the people chosen,” Ruvkun said. “The Nobel Prize is a recognition that generates about 100 times as much press and cheers as any other award. So it&#39;s not part of a continuum. It’s a quantum leap.”</p>
<p>Accepting his award in December might be the third time he has attended a Nobel ceremony in Stockholm, having watched his mentor Robert Horvitz in 2002 and his 2009 winning pal Jack Szostak.</p>
<p>“A journey is coming. It will be the third, possibly the best,” Ruvkun said.</p>
<p>Ambros said he didn&#8217;t expect the award because he believed the Nobel Committee had already highlighted RNA within the 2006 prize, which went to his friends Andrew Fire and Craig Mello.</p>
<p>&#8220;It represents a recognition of how wonderful and unexpected discoveries arise from a curiosity in basic research funded by taxpayer dollars.&#8221; &#8220;It&#39;s an extremely important message, probably the most important message, that this investment is really paying off,&#8221; he said.</p>
<p><a href="https://apnews.com/article/nobel-prize-medicine-71306bd18785477f3a85a69caa6e09c9?utm_source=copy&#038;utm_medium=share">Last 12 months,</a> The Nobel Prize in Physiology or Medicine went to Hungarian-American Katalin Karikó and American Drew Weissman for discoveries that enabled the event of mRNA vaccines against COVID-19, which were crucial to slowing the pandemic.</p>
<p>The price <a href="https://apnews.com/article/nobel-prize-increase-award-amount-122839c6c00d7659f60f4676004c89eb">is endowed with a money prize of 11 million Swedish crowns</a> ($1 million) from a bequest from the prize&#39;s initiator, the Swedish inventor Alfred Nobel.</p>
<p>The Nobel announcements proceed with the Physics Prize on Tuesday, the Chemistry Prize on Wednesday and the Literature Prize on Thursday. The Nobel Peace Prize might be announced on Friday and the Nobel Prize in Economic Sciences on October 14th.</p>
<p>___</p>
<p>This story has been updated to make clear that microRNA helps regulate gene activity slightly than containing instructions for making proteins.</p>
<p>___</p>
<p>Corder reported from The Hague, Netherlands, Cheng reported from London. Associated Press journalists Steven Senne and Rodrique Ngowi in Newton, Massachusetts, and Adithi Ramakrishnan in New York.</p>
<p>Originally published: <time datetime="2024-10-07 10:24:09">October 7, 2024 at 10:24 am</time></p>
</div>
<p><em>image credit : www.mercurynews.com</em></p>
]]></content:encoded>
					
		
		
		<media:content url="https://www.mercurynews.com/wp-content/uploads/2024/10/cnn-L19jb21wb25lbnRzL2ltYWdlL2luc3RhbmNlcy9jbTF5djM0NzgwMDAxM2I2bTN6dG05eWRj-L19jb21wb25lbnRzL2FydGljbGUvaW5zdGFuY2VzL2NtMXlyZ2o1MDAwMG50YnBjY2YxNDZma2g.jpg?w=1024&#038;h=682" medium="image"></media:content>
	</item>
		<item>
		<title>MicroRNA is the Nobel Prize-winning master regulator of the genome – researchers are learning to treat disease by harnessing the way in which it controls genes</title>
		<link>https://bloggingthree.soflytech.com/2024/10/microrna-is-the-nobel-prize-winning-master-regulator-of-the-genome-researchers-are-learning-to-treat-disease-by-harnessing-the-way-in-which-it-controls-genes/</link>
		
		<dc:creator><![CDATA[chandankumarsoft]]></dc:creator>
		<pubDate>Mon, 07 Oct 2024 15:26:07 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[controls]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[genes]]></category>
		<category><![CDATA[genome]]></category>
		<category><![CDATA[harnessing]]></category>
		<category><![CDATA[learning]]></category>
		<category><![CDATA[master]]></category>
		<category><![CDATA[MicroRNA]]></category>
		<category><![CDATA[Nobel]]></category>
		<category><![CDATA[Prizewinning]]></category>
		<category><![CDATA[regulator]]></category>
		<category><![CDATA[researchers]]></category>
		<category><![CDATA[treat]]></category>
		<guid isPermaLink="false">https://bloggingthree.soflytech.com/?p=16804</guid>

					<description><![CDATA[When Victor Ambrose And Gary Ruvkun When they found a brand new molecule within the Nineteen Eighties that they called microRNA, it was an intriguing change from what had been called “microRNA” for a long time central dogma of molecular biology. Recognized with the 2024 Nobel Prize in Physiology or MedicineAmbros and Ruvkun had identified [&#8230;]]]></description>
										<content:encoded><![CDATA[<p></p>
<div itemprop="articleBody">
<p>When <a href="https://www.umassmed.edu/ambroslab/">Victor Ambrose</a> And <a href="https://www.ruvkun.hms.harvard.edu/dr-gary-ruvkun">Gary Ruvkun</a> When they found a brand new molecule within the Nineteen Eighties that they called microRNA, it was an intriguing change from what had been called “microRNA” for a long time <a href="https://www.genome.gov/genetics-glossary/Central-Dogma">central dogma of molecular biology</a>. </p>
<p>Recognized with the <a href="https://www.nobelprize.org/prizes/medicine/2024/press-release/">2024 Nobel Prize in Physiology or Medicine</a>Ambros and Ruvkun had identified a brand new form of genetic material that modified researchers&#39; understanding of gene regulation.</p>
<p>RNA, like DNA, is a type of genetic material that consists of individual nucleotides linked together into chains. According to the central dogma, genetic information flows in a single direction: DNA is transcribed into RNA, and RNA is translated into proteins. But in a significant departure from central dogma, some RNAs are never translated or encoded into proteins.</p>
<p><a href="https://www.ibiology.org/genetics-and-gene-regulation/introduction-to-micrornas/">MicroRNA</a> is a form of these so-called non-coding RNAs. These are short sections of genetic material that don&#8217;t themselves code for a particular protein, but fairly control the RNAs that code for proteins. In fact, microRNAs turn certain genes on and off.</p>
<p>I <a href="https://scholar.google.com/citations?user=4JMQMLgAAAAJ&#038;hl=en">dedicated my scientific profession</a> to know how RNA works, partly because research on RNA lags behind other macromolecules comparable to DNA and proteins. The Nobel Prize recognition for microRNA molecules highlights each their importance in biology and their promise as a possible treatment for various diseases, including cancer.</p>
<figure>
<p><iframe title="Gene Silencing by Micro RNA - Medical Animation" width="1170" height="658" src="https://www.youtube.com/embed/t5jroSCBBwk?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe></p><figcaption><span class="caption">MicroRNAs play a key role in regulating gene expression.</span></figcaption></figure>
<h2>MicroRNAs and disease</h2>
<p>Scientists consider microRNAs as <a href="https://doi.org/10.1146/annurev-pharmtox-010510-100517">Master regulators of the genome</a> because of their ability to bind to and alter the expression of many protein-coding RNAs. In fact, a single microRNA can regulate between 10 and 100 protein-coding RNAs. Instead of translating DNA into proteins, they&#8217;ll as an alternative bind to protein-coding RNAs to silence genes. </p>
<p>The reason microRNAs can regulate such a various pool of RNA is because of their ability to bind to focus on RNAs with which they don&#8217;t perfectly match. This signifies that a single microRNA can often regulate a pool of targets, all involved in similar processes within the cell, leading to an enhanced response.</p>
<p>Because a single microRNA can regulate multiple genes, many microRNAs can contribute to disease after they stop functioning.</p>
<p>In 2002, researchers first identified the role of dysfunctional microRNAs within the disease of patients with a particular form of blood and bone marrow cancer <a href="https://doi.org/10.1073/pnas.242606799">chronic lymphocytic leukemia</a>. This cancer results from the <a href="https://doi.org/10.1038/cdd.2009.69">Loss of two microRNAs</a> normally involved in blocking tumor cell growth. Since then, scientists have identified <a href="https://mirbase.org/browse/results/?organism=hsa">over 2,000 microRNAs in humans</a>a lot of that are altered in various diseases. </p>
<p>The field has developed a reasonably solid understanding of how microRNA dysfunction contributes to disease. Changing one microRNA can alter several other genes, leading to a wide range of changes that may overall alter the cell&#39;s physiology. For example, greater than half of all cancers show significantly reduced activity <a href="https://doi.org/10.3389/fcell.2021.640587">microRNA called miR-34a</a>. Because miR-34a regulates many genes involved in stopping cancer cell growth and migration, lack of miR-34a may increase the chance of cancer.</p>
<p>Researchers are considering using microRNAs as a therapeutic against cancer, heart disease, neurodegenerative diseases and others. While the ends in the laboratory were promising, the introduction of microRNA treatments within the clinic was promising <a href="https://doi.org/10.1016/j.tig.2022.02.006">overcome several challenges</a>. Many of those are related to inefficient delivery to focus on cells and poor stability, which limits their effectiveness.</p>
<figure class="align-center zoomable">
<div class="placeholder-container" style="--aspect-ratio-percent:64.19098143236074%;--background-color:#9a62a7"><img decoding="async" alt="Diagram showing a loop of microRNA binding to an mRNA strand as it is translated from DNA" class="lazyload" src="https://images.theconversation.com/files/561975/original/file-20231127-26-jqjjuh.png?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=754&#038;fit=clip" srcset="https://images.theconversation.com/files/561975/original/file-20231127-26-jqjjuh.png?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=600&#038;h=385&#038;fit=crop&#038;dpr=1 600w, https://images.theconversation.com/files/561975/original/file-20231127-26-jqjjuh.png?ixlib=rb-4.1.0&#038;q=30&#038;auto=format&#038;w=600&#038;h=385&#038;fit=crop&#038;dpr=2 1200w, https://images.theconversation.com/files/561975/original/file-20231127-26-jqjjuh.png?ixlib=rb-4.1.0&#038;q=15&#038;auto=format&#038;w=600&#038;h=385&#038;fit=crop&#038;dpr=3 1800w, https://images.theconversation.com/files/561975/original/file-20231127-26-jqjjuh.png?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=754&#038;h=484&#038;fit=crop&#038;dpr=1 754w, https://images.theconversation.com/files/561975/original/file-20231127-26-jqjjuh.png?ixlib=rb-4.1.0&#038;q=30&#038;auto=format&#038;w=754&#038;h=484&#038;fit=crop&#038;dpr=2 1508w, https://images.theconversation.com/files/561975/original/file-20231127-26-jqjjuh.png?ixlib=rb-4.1.0&#038;q=15&#038;auto=format&#038;w=754&#038;h=484&#038;fit=crop&#038;dpr=3 2262w" sizes="(min-width: 1466px) 754px, (max-width: 599px) 100vw, (min-width: 600px) 600px, 237px"></div><figcaption>
              <span class="caption">MicroRNA can silence genes by binding to mRNA.</span><br />
              <span class="attribution"><a class="source" href="https://commons.wikimedia.org/wiki/File:Conceptual_overview_of_multiomics_-_digital_skewed.png">Kajsa Mollersen/Wikimedia Commons</a>, <a class="license" href="http://creativecommons.org/licenses/by-sa/4.0/">CC BY-SA</a></span><br />
            </figcaption></figure>
<h2>Delivery of microRNA to cells</h2>
<p>One reason it&#8217;s difficult to deliver microRNA treatments into cells is that microRNA treatments should be targeted to diseased cells while avoiding healthy cells. Unlike mRNA COVID-19 vaccines, that are taken up by scavenging immune cells whose job is to acknowledge foreign materials, microRNA treatments must trick the body into considering they will not be foreign to avoid an immune attack and change into the intended ones cells to achieve.</p>
<p>Scientists are exploring alternative ways to deliver microRNA treatments to their specific goal cells. One method that&#8217;s attracting a whole lot of attention relies on direct use <a href="https://doi.org/10.1093/narcan/zcab030">Linking the microRNA with a ligand</a>a form of small molecule that binds to certain proteins on the cell surface. Compared to healthy cells, diseased cells can have a disproportionate variety of surface proteins or receptors. Ligands can subsequently help microRNAs reach diseased cells in a targeted manner while avoiding healthy cells. The first ligand approved by the US Food and Drug Administration to deliver small RNAs comparable to microRNAs, <a href="https://doi.org/10.1007/s40265-020-01269-0">N-Acetylgalactosamine or GalNAc</a>delivers RNAs preferentially to liver cells.</p>
<p>To discover ligands that may deliver small RNAs to other cells, receptors should be found which can be expressed at sufficiently high levels on the surface of the goal cells. Typically, <a href="https://doi.org/10.1038/nrd4519">over one million copies per cell</a> are required to attain sufficient delivery of the drug.</p>
<p>One distinguished ligand is folic acid, also called vitamin B9, a small molecule that&#8217;s critical during times of rapid cell growth, comparable to fetal development. Because some tumor cells have one million folate receptors, this ligand provides ample opportunity to deliver enough therapeutic RNA to combat various sorts of cancer. For example, my lab developed a brand new molecule <a href="https://doi.org/10.1126/scitranslmed.aam9327">called FolamiR-34a</a> – folate linked to miR-34a – which reduced the dimensions of breast and lung cancer tumors in mice.</p>
<figure class="align-center zoomable">
<div class="placeholder-container" style="--aspect-ratio-percent:64.45623342175067%;--background-color:#35576a"><img decoding="async" alt="Microscopic image juxtaposing endothelial cells sprouting expansions to form new blood vessels and a cell bathed in microRNA and unable to sprout" class="lazyload" src="https://images.theconversation.com/files/561976/original/file-20231127-18-5pbfrd.jpg?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=754&#038;fit=clip" srcset="https://images.theconversation.com/files/561976/original/file-20231127-18-5pbfrd.jpg?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=600&#038;h=387&#038;fit=crop&#038;dpr=1 600w, https://images.theconversation.com/files/561976/original/file-20231127-18-5pbfrd.jpg?ixlib=rb-4.1.0&#038;q=30&#038;auto=format&#038;w=600&#038;h=387&#038;fit=crop&#038;dpr=2 1200w, https://images.theconversation.com/files/561976/original/file-20231127-18-5pbfrd.jpg?ixlib=rb-4.1.0&#038;q=15&#038;auto=format&#038;w=600&#038;h=387&#038;fit=crop&#038;dpr=3 1800w, https://images.theconversation.com/files/561976/original/file-20231127-18-5pbfrd.jpg?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=754&#038;h=486&#038;fit=crop&#038;dpr=1 754w, https://images.theconversation.com/files/561976/original/file-20231127-18-5pbfrd.jpg?ixlib=rb-4.1.0&#038;q=30&#038;auto=format&#038;w=754&#038;h=486&#038;fit=crop&#038;dpr=2 1508w, https://images.theconversation.com/files/561976/original/file-20231127-18-5pbfrd.jpg?ixlib=rb-4.1.0&#038;q=15&#038;auto=format&#038;w=754&#038;h=486&#038;fit=crop&#038;dpr=3 2262w" sizes="(min-width: 1466px) 754px, (max-width: 599px) 100vw, (min-width: 600px) 600px, 237px"></div><figcaption>
              <span class="caption">Tumors can exploit healthy cells to grow blood vessels that provide them with nutrients, as seen within the endothelial cells on the left emerging from the expansion. However, when these cells are exposed to certain microRNAs, this growth will be inhibited, as seen within the cell on the best.</span><br />
              <span class="attribution"><a class="source" href="https://flic.kr/p/2hrJ3g4">Dudley Lab, University of Virginia School of Medicine/NIH via Flickr</a>, <a class="license" href="http://creativecommons.org/licenses/by-nc/4.0/">CC BY-NC</a></span><br />
            </figcaption></figure>
<h2>Making microRNAs more stable</h2>
<p>Another challenge with using small RNAs is their <a href="https://doi.org/10.1093/narcan/zcab030">poor stability</a>which ends up in their rapid degradation. Therefore, RNA-based treatments are generally short-lived within the body and require frequent doses to keep up a therapeutic effect. </p>
<p>To overcome this challenge, researchers must <a href="https://doi.org/10.1093/narcan/zcab030">Modification of small RNAs</a> in alternative ways. While each RNA requires a particular pattern of modification, successful modifications can <a href="https://doi.org/10.1038/s41388-023-02801-8">significantly increase their stability</a>. This reduces the necessity for frequent dosing, which in turn reduces treatment burden and costs. </p>
<p>For example, <a href="https://doi.org/10.1089%2Fnat.2018.0736">modified GalNAc siRNAs</a>one other type of small RNAs, reduces the dosage in non-dividing cells from every few days to once every six months. My team has evolved <a href="https://doi.org/10.1038/s41388-023-02801-8">Folate ligands</a> related to modified microRNAs for cancer treatment, which reduced the dosage from once every other day to once per week. In diseases comparable to cancer, where cells divide rapidly and quickly dilute the delivered microRNA, this increase in activity is a major advance in the sphere. We anticipate that this success will facilitate further development of this folate-bound microRNA as a cancer treatment in the approaching years.</p>
<p>Many laboratories are working to develop treatments based on the discoveries a long time ago by recent Nobel laureates Ambros and Ruvkun. While there continues to be much work to be done to beat the hurdles related to microRNA treatments, it is obvious that RNA holds promise as a therapeutic agent for a lot of diseases.</p>
<p><em>This is an updated version of an article originally published on November 29, 2023.</em></p>
</p></div>
<p><em>image credit : theconversation.com</em></p>
]]></content:encoded>
					
		
		
		<media:content url="https://images.theconversation.com/files/623920/original/file-20241007-16-2w4fn2.jpg?ixlib=rb-4.1.0&#038;rect=0%2C0%2C2309%2C1154&#038;q=45&#038;auto=format&#038;w=1356&#038;h=668&#038;fit=crop" medium="image"></media:content>
	</item>
	</channel>
</rss>
